Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04702308
Other study ID # 00137874
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 18, 2021
Est. completion date November 4, 2022

Study information

Verified date November 2023
Source University of Utah
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is an extension of a planned quality improvement project that aims to promote standard of care by increasing the use of evidence-based clinical decision rules amongst emergency medicine providers in the University of Utah Emergency Department. Patient-specific information from the EHR will be used to recommend the use of relevant clinical decision rules to emergency medicine providers at the point-of-care. These recommendations will be in the form of non-interruptive alerts with one-click access to the suggested decision rules through the MDCalc Connect EHR add-on application. Specific aims of the study are to determine if 1) patient-specific non-interruptive alerts increase the use of clinical decision rules amongst emergency medicine providers and 2) an increase in the use of clinical decision rules affects provider ordering habits.


Recruitment information / eligibility

Status Completed
Enrollment 70
Est. completion date November 4, 2022
Est. primary completion date November 18, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 16 Years and older
Eligibility Patient Inclusion Criteria: - 16 years of age or older - Qualifying chief complaint* Patient Exclusion Criteria: - None - A full list of the qualifying chief complaints is provided in Appendix A of the full research protocol.

Study Design


Intervention

Other:
Clinical Decision Rule Alerts
The

Locations

Country Name City State
United States University of Utah Salt Lake City Utah

Sponsors (1)

Lead Sponsor Collaborator
University of Utah

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Total clinical decision rule usage Composite measure of total number of clinical decision rules used through the MDCalc Connect app. During the intervention
Secondary Individual clinical decision rule usage Number of uses of individual clinical decision rules measured through the MDCalc Connect app. During the intervention
Secondary Computed tomography pulmonary angiography studies The total number of computed tomography pulmonary angiography studies ordered During the intervention
Secondary Computed tomography head studies The total number of computed tomography head without contrast studies ordered During the intervention
Secondary Computed tomography c-spine studies The total number of computed tomography c-spine without contrast studies ordered During the intervention
Secondary Lower extremity ultrasound The total number of lower extremity ultrasound studies ordered During the intervention
Secondary d-dimer tests Total number of d-dimer blood tests ordered During the intervention
Secondary Delta troponin tests Total number of times two or more troponin tests were ordered During the intervention
Secondary Emergency department bounceback rate. 30-day emergency department return visit (or "bounceback") rate Up to 30 days after the intervention
Secondary Admission rate Hospital admission rate During the intervention
See also
  Status Clinical Trial Phase
Recruiting NCT05050617 - Point-of-Care Ultrasound in Predicting Adverse Outcomes in Emergency Department Patients With Acute Pulmonary Embolism
Terminated NCT04558125 - Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary Embolism Phase 4
Not yet recruiting NCT06017271 - Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer
Completed NCT03915925 - Short-term Clinical Deterioration After Acute Pulmonary Embolism
Completed NCT02502396 - Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer Center
Recruiting NCT05171075 - A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE Phase 3
Completed NCT04454554 - Prevalence of Pulmonary Embolism in Patients With Dyspnea on Exertion (PEDIS)
Completed NCT03173066 - Ferumoxytol as a Contrast Agent for Pulmonary Magnetic Resonance Angiography Phase 1
Terminated NCT03002467 - Impact Analysis of Prognostic Stratification for Pulmonary Embolism N/A
Completed NCT02611115 - Optimizing Protocols for the Individual Patient in CT Pulmonary Angiography. N/A
Completed NCT02334007 - Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery Phase 1/Phase 2
Completed NCT01975090 - The SENTRY Clinical Study N/A
Not yet recruiting NCT01357941 - Need for Antepartum Thromboprophylaxis in Pregnant Women With One Prior Episode of Venous Thromboembolism (VTE) N/A
Completed NCT01326507 - Prognostic Value of Heart-type Fatty Acid-Binding Protein (h-FABP) in Acute Pulmonary Embolism N/A
Completed NCT00720915 - D-dimer to Select Patients With First Unprovoked Venous Thromboembolism Who Can Have Anticoagulants Stopped at 3 Months N/A
Completed NCT02476526 - Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney Disease Phase 4
Completed NCT00773448 - Screening for Occult Malignancy in Patients With Idiopathic Venous Thromboembolism N/A
Completed NCT00780767 - Angiojet Rheolytic Thrombectomy in Case of Massive Pulmonary Embolism Phase 2
Completed NCT00771303 - Ruling Out Pulmonary Embolism During Pregnancy:a Multicenter Outcome Study
Completed NCT00244725 - Odiparcil For The Prevention Of Venous Thromboembolism Phase 2